CircFAM120B overexpression suppressed CRC cell proliferation, migration/invasion and glycolysis metabolism and also blocked tumor growth in vivo by targeting the miR-645/TGFBR2 axis. The gene discussed is TGFBR2; the disease is neoplasm.